SI2072041T1 - Postopek za pripravo filmsko obloženih tablet ki vsebujejo drospirenon kot aktivno učinkovino - Google Patents

Postopek za pripravo filmsko obloženih tablet ki vsebujejo drospirenon kot aktivno učinkovino

Info

Publication number
SI2072041T1
SI2072041T1 SI200830763T SI200830763T SI2072041T1 SI 2072041 T1 SI2072041 T1 SI 2072041T1 SI 200830763 T SI200830763 T SI 200830763T SI 200830763 T SI200830763 T SI 200830763T SI 2072041 T1 SI2072041 T1 SI 2072041T1
Authority
SI
Slovenia
Prior art keywords
active agent
coated tablets
tablets containing
preparing film
containing drospirenone
Prior art date
Application number
SI200830763T
Other languages
English (en)
Inventor
Attila Bodis
Istvan Greiner
Kasza Jonathan Mihaly Nagy
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of SI2072041T1 publication Critical patent/SI2072041T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200830763T 2007-12-20 2008-10-06 Postopek za pripravo filmsko obloženih tablet ki vsebujejo drospirenon kot aktivno učinkovino SI2072041T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0700826A HUP0700826A3 (en) 2007-12-20 2007-12-20 Coated tablet containing drospirenone and process for producing the same
EP08462008A EP2072041B1 (en) 2007-12-20 2008-10-06 Method for preparing film-coated tablets containing drospirenone as active agent

Publications (1)

Publication Number Publication Date
SI2072041T1 true SI2072041T1 (sl) 2012-11-30

Family

ID=89987951

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830763T SI2072041T1 (sl) 2007-12-20 2008-10-06 Postopek za pripravo filmsko obloženih tablet ki vsebujejo drospirenon kot aktivno učinkovino

Country Status (23)

Country Link
US (1) US20110002993A1 (sl)
EP (2) EP2072041B1 (sl)
JP (1) JP5679819B2 (sl)
CN (1) CN101896166B (sl)
AU (1) AU2008339588B2 (sl)
BR (1) BRPI0820450A2 (sl)
CA (1) CA2708875A1 (sl)
CY (1) CY1113416T1 (sl)
DK (1) DK2072041T3 (sl)
EA (1) EA017869B1 (sl)
ES (1) ES2391953T3 (sl)
HK (1) HK1147054A1 (sl)
HR (1) HRP20120815T1 (sl)
HU (1) HUP0700826A3 (sl)
IL (1) IL205818A (sl)
MY (1) MY148138A (sl)
NZ (1) NZ585554A (sl)
PL (1) PL2072041T3 (sl)
PT (1) PT2072041E (sl)
SI (1) SI2072041T1 (sl)
UA (1) UA103182C2 (sl)
WO (1) WO2009081216A1 (sl)
ZA (1) ZA201003913B (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160048305A1 (en) * 2014-08-14 2016-02-18 Microsoft Corporation Group-Based User Interface Rearrangement
RU2753049C2 (ru) * 2016-08-04 2021-08-11 БиПиЭсАй ХОЛДИНГЗ, ЭлЭлСи Легкие для глотания покрытия и покрытые ими субстраты
EP3747364A4 (en) * 2018-01-29 2021-11-10 PHC Holdings Corporation PROTECTIVE FILM MATERIAL FOR BIOCAPTER PROBE
WO2019176339A1 (ja) * 2018-03-13 2019-09-19 Phcホールディングス株式会社 バイオセンサプローブ用保護膜材料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3022337A1 (de) 1980-06-11 1982-01-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
EP2044941A1 (en) * 1999-08-31 2009-04-08 Bayer Schering Pharma AG Multiple-phase formulation of drospirenone and estradiol as a contraceptive
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
EP1216713A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
JP2004315713A (ja) * 2003-04-18 2004-11-11 Shin Etsu Chem Co Ltd 非イオン性セルロースエーテルの製造方法及びこれにより得られる非イオン性セルロースエーテル造粒物
EP1625849A1 (en) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
US8475838B2 (en) * 2005-06-03 2013-07-02 Sandoz Ag Rapidly-dissolving pharmaceutical composition for inhibiting ovulation
EP1767194A1 (de) * 2005-06-09 2007-03-28 Helm AG Verfahren zur Herstellung von Adsorbaten des Drospirenons

Also Published As

Publication number Publication date
JP2011507825A (ja) 2011-03-10
CN101896166A (zh) 2010-11-24
PL2072041T3 (pl) 2012-12-31
NZ585554A (en) 2012-06-29
JP5679819B2 (ja) 2015-03-04
HUP0700826A3 (en) 2010-03-29
AU2008339588A1 (en) 2009-07-02
CA2708875A1 (en) 2009-07-02
UA103182C2 (ru) 2013-09-25
ZA201003913B (en) 2011-03-30
IL205818A0 (en) 2010-11-30
EP2446880A1 (en) 2012-05-02
IL205818A (en) 2016-05-31
DK2072041T3 (da) 2012-11-05
MY148138A (en) 2013-02-28
WO2009081216A1 (en) 2009-07-02
US20110002993A1 (en) 2011-01-06
CY1113416T1 (el) 2016-06-22
HU0700826D0 (en) 2008-02-28
HK1147054A1 (en) 2011-07-29
EP2072041B1 (en) 2012-08-01
EP2072041A1 (en) 2009-06-24
ES2391953T3 (es) 2012-12-03
HRP20120815T1 (hr) 2012-11-30
PT2072041E (pt) 2012-10-31
CN101896166B (zh) 2013-05-01
EA017869B1 (ru) 2013-03-29
AU2008339588B2 (en) 2014-06-26
HUP0700826A2 (en) 2009-07-28
EA201001032A1 (ru) 2010-12-30
BRPI0820450A2 (pt) 2015-06-16

Similar Documents

Publication Publication Date Title
HRP20161312T1 (hr) Postupak za pripravu farmaceutske formulacije kontrastnih sredstava
IL225637A0 (en) The compositions, tablets containing such compositions, their use and a process for their preparation
AP2577A (en) Process for preparing diaminophenothiazinium compounds
IL237642A (en) METHOD FOR PREPARING PHARMACEUTICAL MATERIALS
IL210982A0 (en) Process for preparing azacytidine intermediate
HK1200697A1 (en) Therapeutic agent for pruritus
IL205759A (en) History of isoxazolo-pyridine, a process for their preparation and the drugs containing them
AP3050A (en) New Benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions comprising them
PT2084128E (pt) Processo para a preparação de isocianatos
AP2756A (en) New dihydroindolone compounds, a process for theirpreparation and pharmaceutical compositions containing them
IL209006A0 (en) Therapeutic agent for male sterility
HK1111160A1 (en) Process for preparing
PT2448920E (pt) Compostos de benzeno-sulfanomidas, os seus processos de síntese e as suas utilizações na medicina
SI2072041T1 (sl) Postopek za pripravo filmsko obloženih tablet ki vsebujejo drospirenon kot aktivno učinkovino
IL196142A0 (en) Process for preparing amidrazones
EP2305223A4 (en) AGENT FOR THE ACTIVATION OF STEM CELLS
GB0716298D0 (en) Process for pharmaceutical compound
PL2142561T3 (pl) Sposób wytwarzania inhibitorów aromatazy
IL195262A0 (en) Process for preparing hydroxylpatite
EP2007681A4 (en) METHOD FOR PRODUCING ULTRAFINE SODIUM BICARBONATE POWDER
AP2009004891A0 (en) New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them
TWI366474B (en) Method for manufacturing dry powder extinguishing agent
GB0720767D0 (en) Method for making pharmaceutical compounds
EP2206510A4 (en) THERAPEUTIC AGENT FOR DIABETES